Distribution date: 24 May 2024

The Law aims to achieve a high level of protection of human health and consumer interests in relation to food safety, taking into account the diversity of the supply of food products, including traditional products, ensuring the efficient functioning of the national market. The amended Art. 22, paragraph 2 of the Law 306/2018 - Export of food products and feed for animals from the Republic of Moldova states the following: (2)  At the request of the food operator, the National Food Safety Agency certifies the safety of food products intended for export or re-export by issuing a HEALTH CERTIFICATE. The HEALTH CERTIFICATE is issued following the results of laboratory tests carried out by the reference laboratory or an accredited laboratory, which confirm the conformity of the food products with the food regulations of the exporting country. When performing the laboratory tests, the samples are taken by the authority issuing the certificate. The HEALTH CERTIFICATE model is presented in annex no. 2. The scope of the amended provisions is the harmonization of the national legislation with the Regulation (EC) no. 178/2002 of the European Parliament and of the Council of the European Union of 28 January 2002 establishing the principles and general requirements of food legislation, establishing the European Food Safety Authority and establishing procedures in the field of food safety, published in the Official Journal of the European Union L 31 of 1 February 2002, as last amended by Regulation (EU) 2017/745.

Products Covered: Edible vegetables and certain roots and tubers (HS code(s): 07); Edible fruit and nuts; Peel of citrus fruit or melons (HS code(s): 08); Coffee, tea, maté and spices (HS code(s): 09); Cereals (HS code(s): 10); Products of the milling industry; Malt; Starches; Inulin; Wheat gluten (HS code(s): 11); Oil seeds and oleaginous fruits; Miscellaneous grains, seeds and fruit; Industrial or medicinal plants; Straw and fodder (HS code(s): 12); Lac; Gums, resins and other vegetable saps and extracts (HS code(s): 13); Animal, vegetable or microbial fats and oils and their cleavage products; Prepared edible fats; Animal or vegetable waxes (HS code(s): 15); Sugars and sugar confectionery (HS code(s): 17); Cocoa and cocoa preparations (HS code(s): 18); Preparations of cereals, flour, starch or milk; Pastrycooks' products (HS code(s): 19); Preparations of vegetables, fruit, nuts or other parts of plants (HS code(s): 20); Miscellaneous edible preparations (HS code(s): 21); Beverages, spirits and vinegar (HS code(s): 22); Residues and waste from the food industries; prepared animal fodder (HS code(s): 23); Salt; Sulphur; Earths and stone; Plastering materials, lime and cement (HS code(s): 25); Essential oils and resinoids; Perfumery, cosmetic or toilet preparations (HS code(s): 33)

Regulation Type: Regular notification

Distribution date: 22 May 2024 | Final date for Comment: 21 July 2024

This document specifies the terms and definitions, technical requirements, test methods, inspection rules, labeling, packaging, transportation, storage and shelf life of feed additive α-galactosidase. This document applies to the feed additive α-galactosidase prepared by fermentation and separation with or without carrier, using aspergillus niger as strains.

Products Covered: copper chloride hydroxide (HS code(s): 350790); (ICS code(s): 65.120)

Regulation Type: Regular notification

Distribution date: 22 May 2024

Draft Resolution number 889, 24 July 2020 - previously notified through G/TBT/N/BRA/1056 - which establishes technical requirements for the notification, market authorization, and post market authorization for medicinal gases, was adopted as Normative Instruction 301, 17 May 2024  The final text is available only in Portuguese and can be downloaded at:  https://antigo.anvisa.gov.br/documents/10181/3428523/IN_301_2024_.pdf/c49403d9-30b3-4716-ad93-51dd514c34be 

Products Covered: Medicaments (excluding goods of heading No. 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or informs or packings for retail sale. (HS code(s): 3003); Medicaments (excluding goods of heading No. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale. (HS code(s): 3004); Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes. (HS code(s): 3005); Pharmaceutical goods specified in Note 3 to this Chapter. (HS code(s): 3006); Anaesthetic, respiratory and reanimation equipment (ICS code(s): 11.040.10)

Regulation Type: Addendum to Regular Notification

Distribution date: 22 May 2024

Draft Resolution 890, 24 July 2020 - previously notified through G/TBT/N/BRA/1057 - which establishes the lists of medicinal gases subject to notification, was adopted as Resolution 870, 17 May 2024. The final text is available only in Portuguese and can be downloaded at:  https://antigo.anvisa.gov.br/documents/10181/3428523/RDC_870_2024_.pdf/f56f27f3-87be-43c0-ac3d-6393ffa4735a 

Products Covered: Medicaments (excluding goods of heading No. 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or informs or packings for retail sale. (HS code(s): 3003); Medicaments (excluding goods of heading No. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale. (HS code(s): 3004); Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes. (HS code(s): 3005); Pharmaceutical goods specified in Note 3 to this Chapter. (HS code(s): 3006); Anaesthetic, respiratory and reanimation equipment (ICS code(s): 11.040.10)

Regulation Type: Addendum to Regular Notification

Distribution date: 22 May 2024 | Final date for Comment: 21 July 2024

Revision of the Mandatory Standards SI 682 parts 3 and 4, dealing with cribs, to be replaced with SI 11130. This proposed standard revision adopts the European Standard EN 1130:2019/AC: December 2020, with a few changes that appear in the standard's Hebrew section.  The major differences between the old version and this new revised draft standard are as follows:Combines SI 682 parts 3 and 4 into one new standard;Changed the standard's structure to include a new risk-based approach;Adds and updates the test methods;Adds new requirements and test methods for hanging and attaching cribs;Adds new requirements regarding the chemical and thermal risk factors;Adds a rationale in Annex A.Both the old and the new revised standards will apply from entry into force of this revision for a transition period of 6 months. During this time, products may be tested according to the old or the new revised standard. 

Products Covered: Cribs (HS code(s): 9403); (ICS code(s): 97.140; 97.190)

Regulation Type: Regular notification

Distribution date: 21 May 2024

OSHA is amending the Hazard Communication Standard (HCS) to conform to the United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS), primarily Revision 7 (Rev. 7), address issues that arose during the implementation of the 2012 update to the HCS, and provide better alignment with other U.S. agencies and international trading partners, while enhancing the effectiveness of the standard. Consistent with Executive Order 13563 and the Regulatory Flexibility Act, which call for assessment and, where appropriate, modification and improvement of existing rules, OSHA has reviewed the existing HCS. The agency has determined that the revisions in this final rule will enhance the effectiveness of the HCS by ensuring employees are appropriately apprised of the chemical hazards to which they may be exposed, thus reducing the incidence of chemical-related occupational illnesses and injuries. The modifications to the standard include revised criteria for classification of certain health and physical hazards, revised provisions for updating labels, new labeling provisions for small containers, new provisions related to trade secrets, technical amendments related to the contents of safety data sheets (SDSs), and related revisions to definitions of terms used in the standard. This final rule is effective 19 July 2024. The incorporation by reference of certain publications listed in this final rule is approved by the Director of the Federal Register as of 19 July 2024. The incorporation by reference of certain other publications listed in the rule was approved by the Director as of 15 July 2019. Title 29 Code of Federal Regulations (CFR) Part 1910 This final rule and previous actions notified under the symbol G/TBT/N/USA/1697 are identified by Docket Number OSHA-2019-0001. The Docket Folder is available on Regulations.gov at https://www.regulations.gov/docket/OSHA-2019-0001/document and provides access to primary and supporting documents as well as comments received. Documents are also accessible from Regulations.gov by searching the Docket Number.

Products Covered: Chemicals

Regulation Type: Addendum to Regular Notification

Distribution date: 16 May 2024 | Final date for Comment: 15 July 2024

The Ministry of Health published a new draft of regulations titled "Protection of Public Health Regulations (Food) (Import of dietary supplements by a Proper Importer) 5783-2024. The current import regime includes obtaining prior approval for importing dietary supplements, including importing raw materials, and performing a release procedure after inspection at the quarantine station.A registered importer with a valid importer's certificate will be able to register as a Proper Importer of dietary supplements and meet new threshold conditions as specified in the draft of the new regulations, after which he will be able to obtain prior approval to import nutritional supplements. This approval will significantly reduce the waiting time for receiving the import approvals and the release of the products for marketing from the quarantine stations.These proposed regulations require importers of dietary supplements to be thoroughly familiar with the food legislation and the requirements applicable to the product, to implement a safety system based on risk management, and to be responsible for the safety and quality of the imported dietary supplements and to benefit a simplified and quick preliminary import approval.These proposed regulations will enter into force 12 months after publication in Israel's Official Gazette.Nevertheless, for importers that are already registered as Proper Importer the proposed regulations will enter into force on date of publication.

Products Covered: Dietary supplements (HS code(s): 3004); (ICS code(s): 11.120.10; 67.040)

Regulation Type: Regular notification

Distribution date: 14 May 2024 | Final date for Comment: 13 July 2024

This document specifies the basic requirements for the acceptance and hazard classification of explosives, desensitized explosives, and liquid propellants, including acceptance procedures, classification procedures, determination of compatibility groups, requirement of compatibility, and classification test items.This document applies to the hazard assessment of various substances or their products (excluding missiles and nuclear weapons) with deflagrating or explosive characteristics.

Products Covered: explosives, desensitized explosives, liquid propellant (HS code(s): 3601; 3602); (ICS code(s): 13.300; 71.100.30)

Regulation Type: Regular notification

Distribution date: 14 May 2024 | Final date for Comment: 28 July 2024

This Draft Resolution contains provisions on Inspection Guide for Bioavailability/Bioequivalence Centers for Medicines.

Products Covered: Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS code(s): 3003); Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS code(s): 3004)

Regulation Type: Regular notification

Distribution date: 14 May 2024

Resolution 620, 09 March 2022 - previously notified through  G/TBT/N/BRA/1324 - which contains provisions on the Certification of Good Practices for conducting Bioavailability/Bioequivalence studies of medicaments and defines which Bioavailability/Bioequivalence studies of medicines must be carried out in certified research centers, was changed by Resolution 858, 06 May 2024.   

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Addendum to Regular Notification